The Journal of Rheumatology
Playback speed
10 seconds
Systemic Sclerosis-ILD Management: What Is the Safety/Efficacy of the Cyclophosphamide? Can Duration Increase of ILD Therapy Improve Patients Outcomes?
By
The Journal of Rheumatology
FEATURING
Elizabeth R. Volkmann
By
The Journal of Rheumatology
FEATURING
Elizabeth R. Volkmann
25 views
February 18, 2021
Comments 0
Login to view comments.
Click here to Login
Videos